The Effect of Hip Joint Orthotic Intervention and Conventional Exercise Training on Spasticity, Balance and Walking Performance in Children With Cerebral Palsy
1 other identifier
observational
19
1 country
1
Brief Summary
Cerebral palsy (SP) is defined as a group of persistent disorders that cause activity limitation of movement and postural development. Children with cerebral palsy are typically born with a normal anatomical hip sequence. The incidence of hip dysplasia reported in patients with cerebral palsy ranges from 2% to 75%. Various non-surgical measures have been used to prevent or slow the progression of spastic hip dysplasia. The therapy program should include activities designed to sustain hip movement and promote weight bearing. However, there is no convincing evidence that treatment alone prevents hip subluxation. To prevent the progression of hip dysplasia, the physical therapy program should include activities designed to increase the functionality of the buttocks and promote weight bearing. In our study, standing strategies will be applied as conventional therapy. Orthotizing, corrective dynamic elastomeric fabric orthoses and taping applications are often used to prevent hip dysplasia. In our study, TheraTogs orthotic garment part, auxiliary dynamic belt material supporting muscles Tog-Rite will be used.Tog-Rite with a width of 7 cm will be made by applying approximately 50-60% stretch with spiral winding from the hip to the bottom of the knee. Positioning will be taught to families and instructed to wear 4 hours a day. Reminders will be made via remote weekly message, families will be able to reach the therapist at any time. Conventional therapy will continue for 2 sessions per week, 45 minutes in a clinical setting. T0: initial assessment, T1: 3ay conventional therapy, T3: 3 months of conventional therapy + positioning with spasticity, balance and impact on walking will be examined. Socia-demographic information forms of the children taken to the study will be recorded. According to the Gross Motor Function Classification System, children of the GMFCS I- II- III level will be taken to work. Children's independence levels will be determined and recorded with the Functional Independence Measure (WeeFIM). Muscle tone will be assessed by the Modified Ashworth Scale. The Pediatric Berg Balance Scale will be applied for functional balance. Balance measurement will be done with the Becure Balance System. Assessment of the gait will be done through the Gillette functional assessment questionnaire. The walking speed will be done with a 10 meter walking test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 24, 2025
CompletedStudy Start
First participant enrolled
June 2, 2025
CompletedFirst Posted
Study publicly available on registry
June 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedJuly 22, 2025
May 1, 2025
13 days
May 24, 2025
July 19, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Modified Ashworth Scale
From enrollment to the end of treatment at treatment in 0, 3 months and 6 months
Eligibility Criteria
Children with cerebral palsy
You may qualify if:
- age range
- Diagnosis of unilateral or bilateral spastic cerebral palsy
- With a tendency to increase in hip muscle imbalance or hip adduction
- At least 10 meters walkable (with independent or auxiliary device)
- GMFCS I- II- III level according to the gross motor function classification system
You may not qualify if:
- The presence of dysplasia of the hip
- Severe adductor spasticity, Modified Ashworth Scale ≥ 3
- Botulinum toxin injection into lower extremities in the last 6 months
- Use of drugs to reduce spasticity
- The presence of epilepsy
- Mental inadequacy at a level that cannot understand commands
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
İstanbul Medipol University
Istanbul, Beykoz, 34810, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Devrim Tarakcı, Assoc. Dr.
İstanbul Medipol University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 24, 2025
First Posted
June 3, 2025
Study Start
June 2, 2025
Primary Completion
June 15, 2025
Study Completion
December 15, 2025
Last Updated
July 22, 2025
Record last verified: 2025-05